Zuspan Regimen for Magnesium Sulfate Administration
The Zuspan regimen consists of a 4 g IV loading dose of magnesium sulfate given over 3-4 minutes, followed by a continuous IV infusion of 1-2 g/hour (most commonly 1 g/hour) for maintenance, continued for 24 hours postpartum. 1
Loading Dose
- 4 g magnesium sulfate IV administered over 3-4 minutes
- Dilute the 50% solution to a 10% or 20% concentration before IV administration
- 40 mL of 10% solution OR 20 mL of 20% solution
- Provides therapeutic levels almost immediately 1
Maintenance Dose
- 1-2 g/hour by continuous IV infusion using a controlled infusion pump 1
- The 1 g/hour maintenance dose is as effective as 2 g/hour for eclampsia prevention with significantly fewer maternal side effects (22% vs 67-71%) 2
- Continue until seizures cease or for 24 hours postpartum 3
Key Differences from Pritchard Regimen
The Zuspan regimen is entirely intravenous, whereas the Pritchard regimen combines IV and intramuscular routes. The Zuspan approach avoids painful IM injections and provides more consistent serum levels through continuous infusion 4, 5.
Therapeutic Monitoring
Essential safety parameters:
- Patellar reflexes - Loss occurs at 3.5-5 mmol/L (first sign of toxicity) 5
- Respiratory rate - Must remain >12-16 breaths/minute; respiratory paralysis occurs at 5-6.5 mmol/L 5
- Urine output - Maintain >25-30 mL/hour (magnesium is renally excreted) 1
- Target serum magnesium - 1.8-3.0 mmol/L (therapeutic range); 6 mg/100 mL optimal for seizure control 1, 5
Critical Safety Considerations
Maximum dosing limits:
- Total daily dose should not exceed 30-40 g in 24 hours 1
- In severe renal insufficiency, maximum is 20 g/48 hours with frequent serum level monitoring 1
- Never continue beyond 5-7 days - prolonged use causes fetal abnormalities 1
Toxicity progression:
- 3.5-5 mmol/L: Loss of deep tendon reflexes
- 5-6.5 mmol/L: Respiratory depression/paralysis
7.5 mmol/L: Cardiac conduction abnormalities
12.5 mmol/L: Cardiac arrest 5
Antidote: Have calcium gluconate 1 g (10 mL of 10% solution) IV immediately available for reversal of magnesium toxicity 1
Guideline Endorsement
The ISSHP 2018 guidelines explicitly recommend using "the dosing regimens used in the Eclampsia and MAGPIE trials" - which includes the Zuspan regimen - and emphasize that each unit should have a consistent MgSO4 protocol with appropriate monitoring 3. The FDA labeling confirms this as standard dosing for severe preeclampsia and eclampsia 1.
Common Pitfalls
- Avoid fluid overload: Limit total IV fluids to 60-80 mL/hour during magnesium infusion to prevent pulmonary edema in preeclamptic patients with capillary leak 3
- Drug interactions: Magnesium potentiates neuromuscular blockade and can cause excessive hypotension when combined with nifedipine or other calcium channel blockers 6, 1
- Renal function: Always assess baseline renal function; adjust dosing and increase monitoring frequency in renal insufficiency 1